Bharat Parenterals Ltd approved Q2 FY27 results, reporting consolidated revenue of ₹136.28 crore, up 110.9% year on year, and net profit of ₹11.82 crore.
- Revenue rose 45.4% quarter on quarter.
- Operating margin was 17.3%, up 16.0 percentage points year on year and 8.2 points quarter on quarter.
- Net profit compared with losses in Q2 FY26 and Q1 FY27; auditors’ limited reviews reported no material misstatement concerns.